Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...

Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.

The clinic data shows that Evolut TAVR continues to exhibit less bioprosthetic valve dysfunction compared to Edwards Lifesciences’ (EW) SAPIEN TAVR product. I think Medtronic has already made ...

Medtronic's diversified product portfolio aimed at a wide range of chronic diseases spans therapeutic areas including cardiac, diabetes, chronic pain, as well as various products for acute care.

We expect an in-line return from the stock in the next few months. Medtronic belongs to the Zacks Medical - Products industry. Another stock from the same industry, Haemonetics (HAE), has gained 2 ...

Medtronic (NYSE: MDT) recently announced a partnership with Methinks AI to enhance stroke treatment in a number of geographies.

Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...